Praktické lekárnictvo 3-4/2025
Gliflozins – what’s new in practise
Gliflozins represent modern and complex acting drugs with emerging indications. Apart from antidiabetic effects, there is increasing evidence of cardioprotective and renoprotective benefits pushing gliflozins among the standard treatment of patients with heart failure or chronic kidney disease, often without diabetes. Several risks of gliflozins should be acknowledged before their initiation and proper patient education in risks and benefits should be a common part of this initiation process.
Keywords: gliflozins, heart failure, chronic kidney disease, euglycemic ketoacidosis, indications













